Krahn D D, Gosnell B A, Levine A S, Morley J E
Peptides. 1984 Sep-Oct;5(5):861-4. doi: 10.1016/0196-9781(84)90107-4.
Recently, calcitonin gene-related peptide (CGRP), a product of alternative processing of RNA transcripts from the calcitonin gene, has been characterized. CGRP is present in a number of areas of the brain involved in modulating ingestive behaviors. We tested the effect of centrally administered CGRP on ingestive behaviors. ICV CGRP over a dose range of 1 to 10 micrograms suppressed food intake in 24 hr deprived rats and 20 and 10 micrograms decreased spontaneous nocturnal food intake. CGRP was less effective than calcitonin at suppressing food intake. Peripheral CGRP was less effective than centrally administered CGRP. Behaviorally, CGRP treated animals rested more, groomed less and ate less. Central CGRP (10 micrograms) did not alter circulating glucose levels. These results suggest that CGRP in high doses may be centrally active in regulating consummatory behaviors.
最近,降钙素基因相关肽(CGRP),即降钙素基因RNA转录本可变加工的产物,已得到鉴定。CGRP存在于大脑中许多参与调节摄食行为的区域。我们测试了中枢给予CGRP对摄食行为的影响。在1至10微克的剂量范围内,脑室内注射CGRP可抑制24小时禁食大鼠的食物摄入量,20微克和10微克剂量可减少夜间自发食物摄入量。CGRP在抑制食物摄入方面比降钙素效果差。外周给予CGRP的效果比中枢给予CGRP的效果差。行为学上,接受CGRP治疗的动物休息更多、梳理毛发更少且进食更少。中枢给予CGRP(10微克)不会改变循环血糖水平。这些结果表明,高剂量的CGRP可能在中枢调节进食行为方面具有活性。